ACOR
Acorda Therapeutics, Inc.
ACOR
ACOR
Delisted
ACOR was delisted on the 11th of April, 2024.
15 hedge funds and large institutions have $1.94M invested in Acorda Therapeutics, Inc. in 2023 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 12 reducing their positions, and 15 closing their positions.
Holders
15
Holders Change
-15
Holders Change %
-50%
% of All Funds
0.24%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
12
Closed
15
Calls
$347K
Puts
$91K
Net Calls
+$256K
Net Calls Change
+$254K
Top Buyers
| 1 |
1
Royal Bank of Canada
Toronto,
Ontario, Canada
|
$7K |
| 2 |
2
Fidelity Investments
Boston,
Massachusetts
|
$13 |
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
26
Simplex Trading
Chicago,
Illinois
| – | – | -15,416 | Closed |
|
27
Two Sigma Advisers
New York
| – | – | -14,700 | Closed |
|
|
SQA
28
Simon Quick Advisors
Morristown,
New Jersey
| – | – | -14,370 | Closed |
|
|
HF
29
HRT Financial
New York
| – | – | -12,520 | Closed |
|
30
UBS Group
Zurich,
Switzerland
| – | – | -6,025 | Closed |
|
|
CFGS
31
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
32
Citadel Advisors
Miami,
Florida
| – | – | – | – |
|